Literature DB >> 24265332

Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24.

Feng Xu1, Qingling Zhang, Wen Cheng, Zhengyu Zhang, Jiandong Wang, Jingping Ge.   

Abstract

OBJECTIVE: To investigate the role of the microRNAs miR-29b-1-5p (miR-29b-1*) and miR-29c in bladder urothelial cancer (BUC).
METHODS: Levels of miR-29b-1* and miR-29c in normal urothelial cells (HU609) and BUC cells (T24) were determined via quantitative real-time reverse transcription-polymerase chain reaction. T24 cells were transfected with small interfering RNA targeting miR-29b-1* or miR-29c, and cell growth was assessed using 3-(4,5-dimehylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The predicted targets and oncogenic pathways of these microRNAs were determined using bioinformatics analysis.
RESULTS: MiR29b-1* and miR-29c levels were higher in T24 cells than normal urothelial cells. Knockdown of miR-29b-1* or miR-29c suppressed T24 cell growth. Bioinformatic analysis showed that miR-29b-1* and miR-29c co-regulated a subset of putative target genes, about 10% of which have been experimentally validated.
CONCLUSION: Both miR-29b-1* and miR-29c regulate cell growth in BUC. The targets of miR-29b-1* and miR-29c may be functionally associated with proliferation, cell cycle and apoptosis.

Entities:  

Keywords:  Bladder urothelial cancer; cancer initiatome; miR-29b-1-5p; miR-29c; microRNA; onco-miRs

Mesh:

Substances:

Year:  2013        PMID: 24265332     DOI: 10.1177/0300060513505266

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  16 in total

1.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

2.  Regulation of growth of human bladder cancer by miR-192.

Authors:  Yongchao Jin; Jiasun Lu; Jiling Wen; Yinzhou Shen; Xiaofei Wen
Journal:  Tumour Biol       Date:  2015-01-09

3.  Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.

Authors:  Xiaofeng Lei; Lijian Lei; Zhelin Zhang; Zhiqing Zhang; Yan Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Mesenchymal stem cells correct impaired diabetic wound healing by decreasing ECM proteolysis.

Authors:  Junwang Xu; Carlos Zgheib; Maggie M Hodges; Robert C Caskey; Junyi Hu; Kenneth W Liechty
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

5.  Age-associated changes in microRNAs affect the differentiation potential of human mesenchymal stem cells: Novel role of miR-29b-1-5p expression.

Authors:  Nada H Eisa; Periyasamy T Sudharsan; Sergio Mas Herrero; Samuel A Herberg; Brian F Volkman; Alexandra Aguilar-Pérez; Dmitry Kondrikov; Ahmed M Elmansi; Charles Reitman; Xingming Shi; Sadanand Fulzele; Meghan E McGee-Lawrence; Carlos M Isales; Mark W Hamrick; Maribeth H Johnson; Jie Chen; William D Hill
Journal:  Bone       Date:  2021-08-14       Impact factor: 4.398

6.  MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.

Authors:  Yue Teng; Yan Zhang; Kai Qu; Xinyuan Yang; Jing Fu; Wei Chen; Xu Li
Journal:  Oncotarget       Date:  2015-12-01

Review 7.  The heterogeneous landscape of ALK negative ALCL.

Authors:  Elisabetta Mereu; Elisa Pellegrino; Irene Scarfò; Giorgio Inghirami; Roberto Piva
Journal:  Oncotarget       Date:  2017-03-14

8.  miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Authors:  Wan Li; Jie Yi; Xiangjin Zheng; Shiwei Liu; Weiqi Fu; Liwen Ren; Li Li; Dave S B Hoon; Jinhua Wang; Guanhua Du
Journal:  Clin Epigenetics       Date:  2018-05-16       Impact factor: 7.259

Review 9.  The role of miR-29b in cancer: regulation, function, and signaling.

Authors:  Bin Yan; Qiong Guo; Fa-Jun Fu; Zhao Wang; Zhuo Yin; Yong-Bao Wei; Jin-Rui Yang
Journal:  Onco Targets Ther       Date:  2015-03-03       Impact factor: 4.147

10.  Inhibition of miR-29c promotes proliferation, and inhibits apoptosis and differentiation in P19 embryonic carcinoma cells.

Authors:  Bin Chen; Guixian Song; Ming Liu; Lingmei Qian; Lihua Wang; Haitao Gu; Yahui Shen
Journal:  Mol Med Rep       Date:  2016-01-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.